Literature DB >> 3326891

Insulin as a factor of increased androgen production in women with obesity and polycystic ovaries.

R Pasquali1, D Antenucci, F Casimirri, S Venturoli, R Paradisi, R Fabbri, N Melchionda, L Barbara.   

Abstract

To evaluate the possible role of moderate hyperinsulinemia on abnormal androgen secretion, we examined 4 age and weight-matched groups of obese subjects: 2 groups of women with normal menses whose fasting insulin (IRI) levels were less than or equal to 20 microU/ml (OB-I) or greater than or equal to 40 microU/ml (OB-I) and 2 groups of women with polycystic ovaries who were similarly grouped. All subjects underwent an oral glucose tolerance test, blood sex hormone determination and multiple LH determinations. Compared to OB, OB-PCO women showed significantly higher values of LH, androgen and estrogen concentrations. OB-I and OB-II showed similar hormonal patterns. On the contrary, OB-PCO-II presented significantly (p less than 0.05) higher androstenedione concentrations (348.7 +/- 129.9 ng/dl) (m +/- SD) than OB-PCO-I women (237.0 +/- 73.7 ng/dl). These differences were evident despite similar plasma LH concentrations. In conclusion, these results suggest that insulin may be a factor amplifying LH-dependent androgen secretion in hyperandrogenized women with obesity and PCO.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3326891     DOI: 10.1007/BF03346997

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  Obesity with insulin resistance: experimental insights.

Authors:  M G Clark; S Rattigan; D G Clark
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

Review 2.  The polycystic ovary syndrome.

Authors:  S S Yen
Journal:  Clin Endocrinol (Oxf)       Date:  1980-02       Impact factor: 3.478

3.  Insulin binding to human ovaries.

Authors:  J C Jarrett; G Ballejo; J C Tsibris; W N Spellacy
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

4.  Specific insulin binding sites in human ovary.

Authors:  L Poretsky; D Smith; M Seibel; A Pazianos; A C Moses; J S Flier
Journal:  J Clin Endocrinol Metab       Date:  1984-10       Impact factor: 5.958

5.  Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion.

Authors:  M E Geffner; S A Kaplan; N Bersch; D W Golde; E M Landaw; R J Chang
Journal:  Fertil Steril       Date:  1986-03       Impact factor: 7.329

6.  Epidermal growth factor antagonizes ovarian theca-interstitial cytodifferentiation.

Authors:  G F Erickson; E Case
Journal:  Mol Cell Endocrinol       Date:  1983-07       Impact factor: 4.102

7.  Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels.

Authors:  R Pasquali; F Casimirri; S Venturoli; R Paradisi; L Mattioli; M Capelli; N Melchionda; G Labò
Journal:  Acta Endocrinol (Copenh)       Date:  1983-09

8.  Insulin resistance in nonobese patients with polycystic ovarian disease.

Authors:  R J Chang; R M Nakamura; H L Judd; S A Kaplan
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

9.  The association of obesity with infertility and related menstural abnormalities in women.

Authors:  A J Hartz; P N Barboriak; A Wong; K P Katayama; A A Rimm
Journal:  Int J Obes       Date:  1979

10.  Effects of insulin on steroidogenesis in cultured porcine ovarian theca.

Authors:  R L Barbieri; A Makris; K J Ryan
Journal:  Fertil Steril       Date:  1983-08       Impact factor: 7.329

View more
  1 in total

1.  Fat and female fecundity: prospective study of effect of body fat distribution on conception rates.

Authors:  B M Zaadstra; J C Seidell; P A Van Noord; E R te Velde; J D Habbema; B Vrieswijk; J Karbaat
Journal:  BMJ       Date:  1993-02-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.